Enterobacter cloacae

Matthew Imanaka1,2, Wakana Yamashita1,2, Shinjiro Ojima1

  • 1Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Tokyo, 162-8640, Japan.

Scientific reports
|November 6, 2025
PubMed
概括

研究人员确定了三种新型菌体,对抗抗卡巴胺耐药的Enterobacter cloacae复合体 (ECC) 感染有效. 这些菌体显示了菌体治疗的前景,为抗生素耐药细菌提供了新的策略.